← Entities
Public Body
HOSPITAL PROFESSOR DOUTOR FERNANDO FONSECA, EPE
NIF 503035416
· PT
Risk Flags
A1 · Repeat Direct Award
€35,538,664
586 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH
€35,538,664
586 contracts
A2 · Late Publication
€334,484,493
5,386 contracts
Contract published to BASE more than 10 days after the signing date
LOW
€334,484,493
5,386 contracts
A5 · Threshold Splitting
€16,304,606
316 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH
€16,304,606
316 contracts
A9 · Price Overrun
€27,224
2 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH
€27,224
2 contracts
A9 · Abnormal Price Reduction
€250,414,372
3,833 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW
€250,414,372
3,833 contracts
B5 · Benford's Law Deviation
€575,779,450
9,189 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM
€575,779,450
9,189 contracts
Procurement Network
Aggregated links between this entity and connected counterparties
Public view excludes person-level links and tax identifiers.
Loading network…
No connections found for the current filters.
Legend
Focus entity
Public body
Company
Anonymized individual
Signal:
All
A1 · Repeat Direct Award
A2 · Late Publication
A5 · Threshold Splitting
A9 · Price Overrun
A9 · Abnormal Price Reduction
B5 · Benford's Law Deviation
C1 · Missing Supplier NIF
C3 · Missing Mandatory Fields
Page 1 of 1 · 2 results
Aquisição de Medicamentos do foro oncológico e imunomoduladores ao abrigo do CPA 2021-06 para o HFF para o ano 2021
PT · 7776754
A9 · Price Overrun
TEVA PHARMA - PRODU...
Ao abrigo de acor...
€225
2021-07-28
€225
2021-07-28
Aquisição de Medicamentos do foro oncológico e imunomoduladores ao abrigo do CPA 2021-06 para o HFF para o ano 2021
PT · 7776776
A9 · Price Overrun
MERCK SHARP & DOHME...
Ao abrigo de acor...
€225
2021-07-28
€225
2021-07-28
Overview
Total Contracts
10,020
Score 305690 · CRITICAL RISK
Digit Distribution
n = 9,189 contracts
· χ² = 62.4267
1
29.8%
2
15.8%
3
12.3%
4
9.8%
5
8.7%
6
7.1%
7
6.5%
8
4.5%
9
5.5%
Observed
Expected (Benford)